ResMed Announces Participation in the 20th Annual Morgan Stanley Global Healthcare Conference

Rhea-AI Summary

ResMed (NYSE: RMD) announced that Rob Douglas, president and COO, will participate in a fireside chat at the 20th Annual Morgan Stanley Global Healthcare Conference on September 12, 2022, at 8:45 a.m. ET in New York City. The event will include a live webcast, with a replay available three hours after it concludes, accessible until March 11, 2023. ResMed focuses on innovative solutions for chronic diseases, aiming to improve quality of life and reduce healthcare costs globally.

Positive

• Engagement in a major healthcare conference may boost visibility and investor confidence.
• Focus on digital health technologies supports long-term growth potential.

Negative

• None.

SAN DIEGO, Sept. 06, 2022 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced Rob Douglas, president and chief operating officer, will participate in a fireside chat at the 20^th Annual Morgan Stanley Global Healthcare Conference on Monday, September 12, 2022, beginning at approximately 8:45 a.m. (Eastern Daylight Time) at the Sheraton New York in New York City.

More information about this event, including a live webcast, may be accessed by visiting http://investor.resmed.com. The webcast replay will be available approximately 3 hours after the live webcast ends and will be accessible through March 11, 2023.

About ResMed
At ResMed (NYSE: RMD, ASX: RMD) we pioneer innovative solutions that treat and keep people out of the hospital, empowering them to live healthier, higher-quality lives. Our digital health technologies and cloud-connected medical devices transform care for people with sleep apnea, COPD, and other chronic diseases. Our comprehensive out-of-hospital software platforms support the professionals and caregivers who help people stay healthy in the home or care setting of their choice. By enabling better care, we improve quality of life, reduce the impact of chronic disease, and lower costs for consumers and healthcare systems in more than 140 countries. To learn more, visit ResMed.com and follow @ResMed.

For Investors	For Media
Amy Wakeham	Jayme Rubenstein
+1 858.836.5000	+1 858.836.6798
investorrelations@resmed.com	news@resmed.com

FAQ

When will ResMed participate in the Morgan Stanley Global Healthcare Conference?

ResMed will participate on September 12, 2022, at 8:45 a.m. ET.

Who from ResMed will speak at the conference?

Rob Douglas, president and COO, will speak at the conference.

How can I access the webcast of ResMed's conference participation?

The webcast can be accessed through ResMed's investor relations website.

What is ResMed's focus in healthcare?

ResMed focuses on innovative solutions for chronic diseases to improve quality of life.

Until when will the webcast replay of ResMed's conference be available?

The replay will be available until March 11, 2023.